NISA INVESTMENT ADVISORS, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$75,680
-8.6%
2,745
-0.4%
0.00%0.0%
Q2 2023$82,815
+68342.1%
2,755
-17.4%
0.00%0.0%
Q1 2023$121
-0.8%
3,335
-2.6%
0.00%0.0%
Q4 2022$122
-99.9%
3,4250.0%0.00%0.0%
Q3 2022$117,000
+19.4%
3,425
+1.0%
0.00%0.0%
Q2 2022$98,000
+15.3%
3,390
+28.4%
0.00%0.0%
Q1 2022$85,000
-58.5%
2,640
-60.3%
0.00%
-50.0%
Q4 2021$205,000
+101.0%
6,643
+73.0%
0.00%
+100.0%
Q3 2021$102,000
-11.3%
3,840
+2.7%
0.00%0.0%
Q2 2021$115,000
+27.8%
3,740
+8.4%
0.00%0.0%
Q1 2021$90,000
+3.4%
3,4500.0%0.00%0.0%
Q4 2020$87,000
+29.9%
3,450
+6.8%
0.00%0.0%
Q3 2020$67,000
-88.9%
3,230
-87.3%
0.00%
-83.3%
Q2 2020$606,000
+1453.8%
25,527
+1078.0%
0.01%
Q1 2020$39,000
+5.4%
2,167
+38.3%
0.00%
Q4 2019$37,000
-86.2%
1,567
-84.0%
0.00%
-100.0%
Q3 2019$268,000
-11.8%
9,770
+6.5%
0.00%
-33.3%
Q2 2019$304,000
-5.6%
9,1770.0%0.00%0.0%
Q1 2019$322,000
+2827.3%
9,177
+2767.8%
0.00%
Q4 2018$11,000
-31.2%
3200.0%0.00%
Q3 2018$16,000
-15.8%
3200.0%0.00%
Q2 2018$19,000
+26.7%
3200.0%0.00%
Q1 2018$15,0000.0%320
-13.5%
0.00%
Q4 2017$15,0000.0%3700.0%0.00%
Q3 2017$15,000
-6.2%
3700.0%0.00%
Q2 2017$16,000
+33.3%
3700.0%0.00%
Q1 2017$12,000
-33.3%
370
-47.1%
0.00%
Q4 2016$18,0007000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders